These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
401 related articles for article (PubMed ID: 33777739)
1. Polo-Like Kinase 4's Critical Role in Cancer Development and Strategies for Plk4-Targeted Therapy. Zhang X; Wei C; Liang H; Han L Front Oncol; 2021; 11():587554. PubMed ID: 33777739 [TBL] [Abstract][Full Text] [Related]
2. Discovery of Polo-like Kinase 4 Inhibitors for the Treatment of Cancer: A Mini Patent Review. Shu Y; Liu Y; Bian S; Xie Z; Liao C Mini Rev Med Chem; 2023; 23(1):67-79. PubMed ID: 35657046 [TBL] [Abstract][Full Text] [Related]
3. Non-mitotic functions of polo-like kinases in cancer cells. Raab CA; Raab M; Becker S; Strebhardt K Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188467. PubMed ID: 33171265 [TBL] [Abstract][Full Text] [Related]
4. Autoinhibition and relief mechanism for Polo-like kinase 4. Klebba JE; Buster DW; McLamarrah TA; Rusan NM; Rogers GC Proc Natl Acad Sci U S A; 2015 Feb; 112(7):E657-66. PubMed ID: 25646492 [TBL] [Abstract][Full Text] [Related]
5. Role of Polo-Like Kinase 4 (PLK4) in Epithelial Cancers and Recent Progress in its Small Molecule Targeting for Cancer Management. Garvey DR; Chhabra G; Ndiaye MA; Ahmad N Mol Cancer Ther; 2021 Apr; 20(4):632-640. PubMed ID: 33402398 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of targeting polo-like kinase 4. Lei Q; Yu Q; Yang N; Xiao Z; Song C; Zhang R; Yang S; Liu Z; Deng H Eur J Med Chem; 2024 Feb; 265():116115. PubMed ID: 38199166 [TBL] [Abstract][Full Text] [Related]
7. Autophosphorylation of polo-like kinase 4 and its role in centriole duplication. Sillibourne JE; Tack F; Vloemans N; Boeckx A; Thambirajah S; Bonnet P; Ramaekers FC; Bornens M; Grand-Perret T Mol Biol Cell; 2010 Feb; 21(4):547-61. PubMed ID: 20032307 [TBL] [Abstract][Full Text] [Related]
8. Polo-like kinase 4 homodimerization and condensate formation regulate its own protein levels but are not required for centriole assembly. Ryniawec JM; Buster DW; Slevin LK; Boese CJ; Amoiroglou A; Dean SM; Slep KC; Rogers GC Mol Biol Cell; 2023 Jul; 34(8):ar80. PubMed ID: 37163316 [TBL] [Abstract][Full Text] [Related]
9. Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer. Zeng Y; Li N; Liu W; Zeng M; Cheng J; Huang J J Cancer Res Clin Oncol; 2020 Oct; 146(10):2447-2460. PubMed ID: 32627077 [TBL] [Abstract][Full Text] [Related]
10. PLK4: a promising target for cancer therapy. Zhao Y; Wang X J Cancer Res Clin Oncol; 2019 Oct; 145(10):2413-2422. PubMed ID: 31492983 [TBL] [Abstract][Full Text] [Related]
11. Polo-like kinase 4: the odd one out of the family. Sillibourne JE; Bornens M Cell Div; 2010 Sep; 5():25. PubMed ID: 20920249 [TBL] [Abstract][Full Text] [Related]
12. p53-Dependent and cell specific epigenetic regulation of the polo-like kinases under oxidative stress. Ward A; Hudson JW PLoS One; 2014; 9(1):e87918. PubMed ID: 24498222 [TBL] [Abstract][Full Text] [Related]
13. Polo-like kinase 4 kinase activity limits centrosome overduplication by autoregulating its own stability. Holland AJ; Lan W; Niessen S; Hoover H; Cleveland DW J Cell Biol; 2010 Jan; 188(2):191-8. PubMed ID: 20100909 [TBL] [Abstract][Full Text] [Related]
14. Role of Polo-like Kinases Plk1 and Plk4 in the Initiation of Centriole Duplication-Impact on Cancer. Hoffmann I Cells; 2022 Feb; 11(5):. PubMed ID: 35269408 [TBL] [Abstract][Full Text] [Related]
15. Functional relationship among PLK2, PLK4 and ROCK2 to induce centrosome amplification. Ling H; Hanashiro K; Luong TH; Benavides L; Fukasawa K Cell Cycle; 2015; 14(4):544-53. PubMed ID: 25590559 [TBL] [Abstract][Full Text] [Related]
16. The Polo kinase Plk4 functions in centriole duplication. Habedanck R; Stierhof YD; Wilkinson CJ; Nigg EA Nat Cell Biol; 2005 Nov; 7(11):1140-6. PubMed ID: 16244668 [TBL] [Abstract][Full Text] [Related]
17. SmSak, the second Polo-like kinase of the helminth parasite Schistosoma mansoni: conserved and unexpected roles in meiosis. Long T; Vanderstraete M; Cailliau K; Morel M; Lescuyer A; Gouignard N; Grevelding CG; Browaeys E; Dissous C PLoS One; 2012; 7(6):e40045. PubMed ID: 22768216 [TBL] [Abstract][Full Text] [Related]
18. Use of the Polo-like kinase 4 (PLK4) inhibitor centrinone to investigate intracellular signalling networks using SILAC-based phosphoproteomics. Byrne DP; Clarke CJ; Brownridge PJ; Kalyuzhnyy A; Perkins S; Campbell A; Mason D; Jones AR; Eyers PA; Eyers CE Biochem J; 2020 Jul; 477(13):2451-2475. PubMed ID: 32501498 [TBL] [Abstract][Full Text] [Related]